Skip to content
10-K

Annual Report

BIOLASE, INC.

0000950170-24-034812

← back to feed
Filed
Mar 21, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 14, 2024 32.52M sh
Shares Diluted FY 2023 · Dec 31, 2023 1.28M sh
Shares Diluted restated FY 2023 · Dec 31, 2022 69K sh
Shares Diluted restated FY 2023 · Dec 31, 2021 59K sh
Capex FY 2023 · Dec 31, 2023 $1.31M
Capex FY 2023 · Dec 31, 2022 $3.73M
Capex FY 2023 · Dec 31, 2021 $707K
Operating Cash Flow FY 2023 · Dec 31, 2023 −$14.09M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$26.76M
Operating Cash Flow FY 2023 · Dec 31, 2021 −$16.71M
Long Term Debt FY 2023 · Dec 31, 2023 $11.78M
Long Term Debt FY 2023 · Dec 31, 2022 $13.09M
Short Term Debt FY 2023 · Dec 31, 2023 $2.27M
Short Term Debt FY 2023 · Dec 31, 2022 $700K
Cash And Equivalents FY 2023 · Dec 31, 2023 $6.57M
Cash And Equivalents FY 2023 · Dec 31, 2022 $4.18M
Stockholders Equity FY 2023 · Dec 31, 2023 −$247K
Stockholders Equity FY 2023 · Dec 31, 2022 $4.89M
Stockholders Equity FY 2023 · Dec 31, 2021 $25.21M
Stockholders Equity FY 2023 · Dec 31, 2020 $10.03M
Current Liabilities FY 2023 · Dec 31, 2023 $19.66M
Current Liabilities FY 2023 · Dec 31, 2022 $17.81M
Total Liabilities FY 2023 · Dec 31, 2023 $33.15M
Total Liabilities FY 2023 · Dec 31, 2022 $33.3M
Current Assets FY 2023 · Dec 31, 2023 $24.86M
Current Assets FY 2023 · Dec 31, 2022 $28.96M
Total Assets FY 2023 · Dec 31, 2023 $35.1M
Total Assets FY 2023 · Dec 31, 2022 $38.19M
Eps Diluted FY 2023 · Dec 31, 2023 −$29.44
Eps Diluted restated FY 2023 · Dec 31, 2022 −$418.13
Eps Diluted restated FY 2023 · Dec 31, 2021 −$283.12
Eps Basic FY 2023 · Dec 31, 2023 −$29.44
Eps Basic restated FY 2023 · Dec 31, 2022 −$418.13
Eps Basic restated FY 2023 · Dec 31, 2021 −$283.12
Sga Expense FY 2023 · Dec 31, 2023 $10.22M
Sga Expense FY 2023 · Dec 31, 2022 $12.31M
Sga Expense FY 2023 · Dec 31, 2021 $11.26M
Rd Expense FY 2023 · Dec 31, 2023 $6M
Rd Expense FY 2023 · Dec 31, 2022 $7.27M
Rd Expense FY 2023 · Dec 31, 2021 $6.05M
Net Income FY 2023 · Dec 31, 2023 −$20.63M
Net Income FY 2023 · Dec 31, 2022 −$28.63M
Net Income FY 2023 · Dec 31, 2021 −$16.16M
Operating Income FY 2023 · Dec 31, 2023 −$17.94M
Operating Income FY 2023 · Dec 31, 2022 −$25.34M
Operating Income FY 2023 · Dec 31, 2021 −$16.43M
Gross Profit FY 2023 · Dec 31, 2023 $16.72M
Gross Profit FY 2023 · Dec 31, 2022 $15.91M
Gross Profit FY 2023 · Dec 31, 2021 $16.53M
Cost Of Revenue FY 2023 · Dec 31, 2023 $32.44M
Cost Of Revenue FY 2023 · Dec 31, 2022 $32.55M
Cost Of Revenue FY 2023 · Dec 31, 2021 $22.66M
Revenue FY 2023 · Dec 31, 2023 $49.16M
Revenue FY 2023 · Dec 31, 2022 $48.46M
Revenue FY 2023 · Dec 31, 2021 $39.19M